Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > TEAR > Summary

OccuLogix Inc.
(TEAR)

1.03USD   Down 0.03 (2.83%)   
At 1:12AM IST
 OccuLogix Inc. (NCM:TEAR) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 1.03USD
Trade Time:1:12AM IST
Change:Down 0.03 (2.83%) 
Prev Close:1.06
Open:1.15
Bid:0.88 x 500
Ask:N/A
1y Target Est:1.00
Day's Range:1.03 - 1.15
52wk Range:0.70 - 3.60
Volume:600
Avg Vol (3m):4,939.68
Market Cap:10.16M
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A%)
Add TEAR to Portfolio   Download Data

HEADLINES

 
•OCCULOGIX, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - EDGAR Online  - Tue, Jan 12
•OCCULOGIX, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits - EDGAR Online  - Tue, Jan 12
•OccuLogix (dba TearLab Corporation) Announces Total Equity Raise of $3,000,000 - GlobeNewswire  - Tue, Jan 12
•TearLab Achieves Health Canada Approval - GlobeNewswire  - Wed, Dec 9
•OCCULOGIX, INC. Financials - EDGAR Online Financials  - Thu, Nov 19
•OCCULOGIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - EDGAR Online  - Tue, Nov 17
•OCCULOGIX, INC. Files SEC form 10-Q, Quarterly Report - EDGAR Online  - Sat, Nov 14
•OccuLogix, dba TearLab Corporation, Reports Q3-09 Financial Results - GlobeNewswire  - Fri, Nov 13
•Q3 2009 OccuLogix, Inc. Earnings Release - After Market Close - CCBN  - Thu, Nov 12
•TearLab Corporation to Release Q3-09 Financial Results on November 12 -- Conference Call to Follow - GlobeNewswire  - Thu, Nov 5
» More Headlines for TEAR...

ANALYST

 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
OccuLogix, Inc., an ophthalmic device company, engages in commercializing a proprietary in vitro diagnostic tear testing platform, the TearLab test for dry eye disease.

» Full Company Profile